THE US Food and Drug Administration has approved Gamifant (emapalumab-izsg) for the treatment of pediatric and adult patients with rare immune system disorder primary hemophagocytic lymphohistiocytosis (HLH) - the first drug specifically for the condition.
A Brisbane law firm has filed a class action against pharmaceutical giant Johnson & Johnson for…
THE Australian Medical Association (AMA) has welcomed the development of a national strategy on sexually transmissible infections, but says not enough is being done to tackle rising rates of sexually transmissible infections in vulnerable communities or to help eliminate congenital syphilis.
WITH new research finding that menstrual issues are often normalised or trivialised and undermanaged in young people, the study’s lead author says pharmacists are ideally placed to advise on pain management.